Jean-Christophe Marie Flatin Sells 1,934 Shares of Oatly Group (NASDAQ:OTLY) Stock

Oatly Group AB Sponsored ADR (NASDAQ:OTLY) CEO Jean-Christophe Marie Flatin sold 1,934 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $8.94, for a total transaction of $17,289.96. Following the completion of the transaction, the chief executive officer owned 245,400 shares in the company, valued at $2,193,876. This represents a 0.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oatly Group Stock Performance

Shares of OTLY stock opened at $8.58 on Friday. Oatly Group AB Sponsored ADR has a 12 month low of $8.09 and a 12 month high of $18.84. The company has a debt-to-equity ratio of 43.43, a current ratio of 0.45 and a quick ratio of 0.32. The firm has a market capitalization of $267.95 million, a P/E ratio of -1.72 and a beta of 1.85. The company’s fifty day moving average price is $10.82 and its two-hundred day moving average price is $11.19.

Oatly Group (NASDAQ:OTLY) last issued its quarterly earnings data on Thursday, April 30th. The company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.52. Oatly Group had a negative net margin of 17.06% and a negative return on equity of 432.75%. The firm had revenue of $228.33 million for the quarter, compared to analyst estimates of $214.61 million. On average, research analysts anticipate that Oatly Group AB Sponsored ADR will post -2.77 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on OTLY. Morgan Stanley set a $12.55 target price on shares of Oatly Group in a research report on Thursday, April 30th. Barclays set a $14.00 price objective on shares of Oatly Group and gave the company an “overweight” rating in a research report on Tuesday, April 14th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Oatly Group in a research report on Friday, March 27th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Oatly Group has a consensus rating of “Hold” and a consensus target price of $14.64.

Institutional Trading of Oatly Group

A number of institutional investors have recently made changes to their positions in OTLY. Performa Ltd US LLC lifted its stake in shares of Oatly Group by 16.8% in the 4th quarter. Performa Ltd US LLC now owns 10,100 shares of the company’s stock worth $108,000 after acquiring an additional 1,450 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in Oatly Group during the first quarter valued at approximately $133,000. Geode Capital Management LLC acquired a new stake in Oatly Group during the second quarter valued at approximately $151,000. R Squared Ltd acquired a new stake in shares of Oatly Group during the fourth quarter valued at approximately $155,000. Finally, Van ECK Associates Corp raised its holdings in shares of Oatly Group by 19.0% during the third quarter. Van ECK Associates Corp now owns 11,001 shares of the company’s stock valued at $178,000 after acquiring an additional 1,756 shares during the period. 68.15% of the stock is owned by institutional investors and hedge funds.

About Oatly Group

Oatly Group is a Sweden-based food and beverage company specializing in the development, production and sale of oat-derived dairy alternatives. The company’s product lineup includes oat-based drinks, ice cream, yogurts, spreads and cooking creams, all marketed under the Oatly brand name. By leveraging proprietary processing technology, Oatly extracts the nutritional benefits of oats—such as soluble fiber and plant protein—while delivering taste and texture profiles that closely mimic traditional dairy products.

Founded in 1994 as a spin-off from research at Lund University, Oatly initially focused on exploiting the health and functional benefits of oat beta-glucans.